The synthesis and activity of spiroindane growth hormone secretagogues
β Scribed by James R. Tata; Ravi P. Nargund; Marcia M. Murphy; David B.R. Johnston; Arthur A. Patchett; Kang Cheng; Liente Wei; Wanda W.-S. Chan; Bridget Butler; Thomas M. Jacks; Gerard Hickey; Roy Smith
- Book ID
- 104364888
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 246 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
β¦ Synopsis
The synthesis and activities of a series of spiroindane growth hormone secretagogues is reported. Modification of the benzylic position of the spiroindane has resulted in a dramatic increase in potency resulting in subnanomolar peptidomimetic growth hormone secretagogues. In vivo data demonstrating the good oral activity of these analogs is reported.
π SIMILAR VOLUMES
## Abstract For Abstract see ChemInform Abstract in Full Text.
The preparation of the Merck Growth Hormone Secretagogue; MK-677 is described. A Fischer indole/reduction based strategy provides the novel spiroindoline nucleus of this potent compound. This optimized sequence necessitates the isolation of only one intermediate 10 and provides MK-677 in 48% overall